Cart
sales@molnova.com
17-Methyltestosterone
CAS No. 58-18-4
17-Methyltestosterone( L-589.372 | NSC 139965 | NSC 9701 | RU-24400 )
Catalog No. M15133 CAS No. 58-18-4
17α-Methyltestosterone has similar binding affinity to AR and similar androgenic and anabolic activities as testosterone.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name17-Methyltestosterone
-
NoteResearch use only, not for human use.
-
Brief Description17α-Methyltestosterone has similar binding affinity to AR and similar androgenic and anabolic activities as testosterone.
-
Description17α-Methyltestosterone has similar binding affinity to AR and similar androgenic and anabolic activities as testosterone.
-
In Vitro——
-
In Vivo——
-
SynonymsL-589.372 | NSC 139965 | NSC 9701 | RU-24400
-
PathwayEndocrinology/Hormones
-
TargetAndrogen Receptor (AR)
-
RecptorAndrogen Receptor
-
Research AreaEndocrinology
-
Indication——
Chemical Information
-
CAS Number58-18-4
-
Formula Weight302.45
-
Molecular FormulaC20H30O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESC[C@@]12[C@@](C)(O)CC[C@@]1([H])[C@]3([H])CCC4=CC(CC[C@]4(C)[C@@]3([H])CC2)=O
-
Chemical Name(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gao J, et al. Environ Toxicol Pharmacol. 2014 May;37(3):1157-68.
molnova catalog
related products
-
Atraric acid
Atraric acid derivatives as a new chemical lead structure for novel therapeutic compounds as AR antagonists.
-
RD162
RD162 is a second-generation, orally available antiandrogen that binds to androgen receptor (AR) with IC50 of 30.9 nM.
-
UT-34
UT-34 is a selective and orally active antagonist of second-generation pan-androgen receptor (AR) and degrader(IC50s of 211.7 nM, 262.4 nM and 215.7 nM for wild-type, F876L and W741L AR, respectively), and has anti-prostate cancer efficacy. In LNCaP cells, UT-34 (3-10 μM; 24 hours) treatment inhibits the expression of PSA and FKBP5 and growth of LNCaP cells starting from 100 nM with maximum effect observed at 10 μM.
